Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial
We identified four clinically distinct T2D phenotypes with differential CV risks. Canagliflozin reduced the risk of CV events, irrespective of the phenotype, emphasizing its broad therapeutic acceptability.
Authors
- Amir Razaghizad (ORCID: https://orcid.org/0000-0001-8397-7949)
- Jiayi Ni (ORCID: https://orcid.org/0000-0002-1941-8170)
- Abhinav Sharma (ORCID: https://orcid.org/0000-0002-2346-8330)
- Frédéric Baroz (ORCID: https://orcid.org/0000-0002-8427-9373)
- Jodi D. Edwards (ORCID: https://orcid.org/0000-0002-9275-4787)
- Pedro Marques (ORCID: https://orcid.org/0000-0002-1120-5461)
- Walter Swardfager (ORCID: https://orcid.org/0000-0002-0030-8908)
- Michael A. Tsoukas (ORCID: https://orcid.org/0000-0002-8326-7274)
- Elite Possik (ORCID: https://orcid.org/0000-0003-1578-5819)
- Thomas A. Mavrakanas (ORCID: https://orcid.org/0000-0002-3368-247X)
- Peter P. Liu (ORCID: https://orcid.org/0000-0002-3017-1199)
- João Pedro Ferreira (ORCID: https://orcid.org/0000-0002-2304-6138)
- Thao Thanh Huynh (ORCID: https://orcid.org/0000-0002-5082-1363)
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Ottawa (CA)
- Inserm (FR)
- Universidade do Porto (PT)
- University of Toronto (CA)
- McGill University Health Centre (CA)
- Canada Research Chairs (CA)
- Hospital de São João (PT)
- Ontario Brain Institute (CA)
- Sunnybrook Research Institute
- McGill University (CA)
- Wilfrid Laurier University (CA)
- Université de Lorraine (FR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1111/dom.15768
- Citations
- 7
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.50
Funders
- Mach-Gaensslen Foundation of Canada
- Canada Research Chairs
- Ministry of Colleges and Universities